Recent experimental studies demonstrate that insulin, at concentrations observed in humans with pre-diabetes and used to treat individuals with diabetes mellitus type 2 (type 2 diabetes), inhibits low O2 tension-induced ATP release from human erythrocytes (Hanson et al., 2009). Here, INS is linked to type 2 diabetes mellitus.